Pharma’s Desperate Struggle to Teach Old Data New Tricks

☞ | View the full content of this post. Exclusively available to ASQ Members.

By David Shaywitz

While pharma C-suite executives find themselves increasingly seduced by the promise of “digital transformation,” and especially by the idea of leveraging AI, the lived, on the ground reality within virtually all pharma R&D organizations couldn’t be further removed.

Novartis CEO Vas Narasimhan candidly alluded to this in January when he reflected on his company’s digital transformation journey, and said, “The first thing we’ve learned is the importance of having outstanding data to actually base

☞ | View the full content of this post. Exclusively available to ASQ Members.

Leave a Comment

Your email address will not be published. Required fields are marked *